Question 1
Regular
A patient is receiving doxorubicin as part of treatment for ovarian cancer. Which of these is a possible adverse effect of doxorubicin?
Correct!
Incorrect
The correct answer is: A
Rationale
Cardiotoxicity.
Doxorubicin is well-documented for its potential to induce cardiotoxicity, which can manifest as decreased cardiac function, heart failure, or arrhythmias. This risk is particularly significant due to its mechanism of action, which can impact myocardial cells adversely.
B: Pulmonary toxicity. Doxorubicin does not typically target the lungs, and pulmonary toxicity is more commonly associated with other chemotherapeutic agents, making this option less relevant in this context.
C: Neurotoxicity. While some chemotherapies may cause neurological effects, doxorubicin is primarily known for its cardiac side effects rather than neurotoxic impact, thus rendering this option unsuitable.
D: Hyperuricemia. Elevated uric acid levels are generally linked to conditions like tumor lysis syndrome, not specifically to doxorubicin treatment, which makes this choice less plausible in relation to the drug's profile.
Correct Answer: A
Rationale: Cardiotoxicity.
Doxorubicin is well-documented for its potential to induce cardiotoxicity, which can manifest as decreased cardiac function, heart failure, or arrhythmias. This risk is particularly significant due to its mechanism of action, which can impact myocardial cells adversely.
B: Pulmonary toxicity. Doxorubicin does not typically target the lungs, and pulmonary toxicity is more commonly associated with other chemotherapeutic agents, making this option less relevant in this context.
C: Neurotoxicity. While some chemotherapies may cause neurological effects, doxorubicin is primarily known for its cardiac side effects rather than neurotoxic impact, thus rendering this option unsuitable.
D: Hyperuricemia. Elevated uric acid levels are generally linked to conditions like tumor lysis syndrome, not specifically to doxorubicin treatment, which makes this choice less plausible in relation to the drug's profile.
Question 2
Regular
When giving cisplatin, the nurse is aware that adverse effect of this drug is which condition?
Correct!
Incorrect
The correct answer is: B
Rationale
Kidney damage. Cisplatin is known for its potential nephrotoxic effects, which can lead to renal impairment. This is a significant concern for healthcare providers, necessitating monitoring of kidney function during treatment to prevent serious complications.
A: Alopecia This condition can occur with various chemotherapy agents, but cisplatin primarily targets kidneys, making it less likely to cause hair loss compared to other treatments.
C: Cardiotoxicity While certain chemotherapeutics have cardiotoxic effects, cisplatin is predominantly associated with nephrotoxicity, not significant heart-related adverse events, thus making this option less relevant.
D: Stomatitis Stomatitis may arise from some cancer treatments, but it is not a hallmark side effect of cisplatin, which primarily affects renal function rather than oral mucosa.
Correct Answer: B
Rationale: Kidney damage. Cisplatin is known for its potential nephrotoxic effects, which can lead to renal impairment. This is a significant concern for healthcare providers, necessitating monitoring of kidney function during treatment to prevent serious complications.
A: Alopecia This condition can occur with various chemotherapy agents, but cisplatin primarily targets kidneys, making it less likely to cause hair loss compared to other treatments.
C: Cardiotoxicity While certain chemotherapeutics have cardiotoxic effects, cisplatin is predominantly associated with nephrotoxicity, not significant heart-related adverse events, thus making this option less relevant.
D: Stomatitis Stomatitis may arise from some cancer treatments, but it is not a hallmark side effect of cisplatin, which primarily affects renal function rather than oral mucosa.
Question 3
Regular
The nurse is teaching a class about the various chemotherapy drugs. Which of these statements explains why alkylating drugs are also called 'cell cycle-nonspecific drugs'?
Correct!
Incorrect
The correct answer is: B
Rationale
Alkylating drugs are cytotoxic in any phase of the cell cycle. This characteristic allows them to target and damage DNA regardless of the cell's stage, making them effective against rapidly dividing cancer cells throughout their life cycle.
A: They are cytotoxic during a specific cell cycle. This statement misrepresents alkylating drugs, which target cells across all phases rather than being limited to one specific cycle phase.
C: They are effective against several types of neoplasms. While this is true for alkylating drugs, it does not address their cell cycle-nonspecific nature, which is the key factor in the question.
D: They are more highly differentiated than cell cycle-specific drugs. Differentiation is not relevant to the classification of alkylating agents; their mechanism of action in targeting any cell cycle phase is the crucial point.
Correct Answer: B
Rationale: Alkylating drugs are cytotoxic in any phase of the cell cycle. This characteristic allows them to target and damage DNA regardless of the cell's stage, making them effective against rapidly dividing cancer cells throughout their life cycle.
A: They are cytotoxic during a specific cell cycle. This statement misrepresents alkylating drugs, which target cells across all phases rather than being limited to one specific cycle phase.
C: They are effective against several types of neoplasms. While this is true for alkylating drugs, it does not address their cell cycle-nonspecific nature, which is the key factor in the question.
D: They are more highly differentiated than cell cycle-specific drugs. Differentiation is not relevant to the classification of alkylating agents; their mechanism of action in targeting any cell cycle phase is the crucial point.
Question 4
Regular
What is the nurse's priority action if extravasation of an antineoplastic drug occurs during intravenous (IV) administration?
Correct!
Incorrect
The correct answer is: C
Rationale
Stop the infusion immediately, but leave the IV catheter in place.
This action is crucial as it prevents further leakage of the harmful antineoplastic drug into surrounding tissues while allowing for potential interventions to mitigate damage. By leaving the catheter in, medical professionals can administer antidotes or other treatments effectively.
A: Reduce the infusion rate. Slowing the infusion does not address the immediate danger of extravasation and may allow further drug leakage, exacerbating tissue damage.
B: Remove the IV, and apply warm compresses. Removing the IV can hinder further treatment options and applying warm compresses may worsen the tissue injury caused by the extravasated drug.
D: Change the infusion to normal saline, and inject the area with hydrocortisone. This approach does not prioritize halting the harmful drug's administration and may delay necessary interventions to treat the extravasation effectively.
Correct Answer: C
Rationale: Stop the infusion immediately, but leave the IV catheter in place.
This action is crucial as it prevents further leakage of the harmful antineoplastic drug into surrounding tissues while allowing for potential interventions to mitigate damage. By leaving the catheter in, medical professionals can administer antidotes or other treatments effectively.
A: Reduce the infusion rate. Slowing the infusion does not address the immediate danger of extravasation and may allow further drug leakage, exacerbating tissue damage.
B: Remove the IV, and apply warm compresses. Removing the IV can hinder further treatment options and applying warm compresses may worsen the tissue injury caused by the extravasated drug.
D: Change the infusion to normal saline, and inject the area with hydrocortisone. This approach does not prioritize halting the harmful drug's administration and may delay necessary interventions to treat the extravasation effectively.
Question 5
Regular
A patient is receiving a third session of chemotherapy with daunorubicin. The nurse will assess the patient for which signs of a potential severe toxic effect of this drug?
Correct!
Incorrect
The correct answer is: C
Rationale
A weight gain of 2 pounds or more in 24 hours. This indicates fluid retention, a potential sign of cardiotoxicity associated with daunorubicin, necessitating close monitoring of the patient’s cardiovascular status.
A: Tinnitus and hearing loss. These symptoms are typically associated with ototoxic medications, not daunorubicin, which primarily poses risks related to cardiotoxicity and hematologic effects.
B: Numbness and tingling in the fingers. Peripheral neuropathy can occur with certain chemotherapeutic agents, but daunorubicin is more closely linked to cardiac side effects rather than neurological symptoms.
D: Decreased blood urea nitrogen and creatinine levels. Daunorubicin does not primarily affect renal function in a way that would lower these levels; it’s more related to its impact on the heart.
Correct Answer: C
Rationale: A weight gain of 2 pounds or more in 24 hours. This indicates fluid retention, a potential sign of cardiotoxicity associated with daunorubicin, necessitating close monitoring of the patient’s cardiovascular status.
A: Tinnitus and hearing loss. These symptoms are typically associated with ototoxic medications, not daunorubicin, which primarily poses risks related to cardiotoxicity and hematologic effects.
B: Numbness and tingling in the fingers. Peripheral neuropathy can occur with certain chemotherapeutic agents, but daunorubicin is more closely linked to cardiac side effects rather than neurological symptoms.
D: Decreased blood urea nitrogen and creatinine levels. Daunorubicin does not primarily affect renal function in a way that would lower these levels; it’s more related to its impact on the heart.
Question 6
Regular
The nurse is hanging a new infusion bag of a chemotherapy drug, but the tubing becomes disconnected and a small amount of the solution drips onto the floor. Which action by the nurse is appropriate?
Correct!
Incorrect
The correct answer is: C
Rationale
Use a spill kit to clean the area.
Utilizing a spill kit is essential in managing hazardous substances like chemotherapy drugs. It ensures proper containment and minimizes exposure risks, adhering to safety protocols that protect both staff and patients, thereby maintaining a safe environment.
A: Let it dry, and then mop the floor. Allowing the chemical solution to dry poses significant health risks, as it can aerosolize and become hazardous, complicating safe cleanup.
B: Wipe the area with a disposable paper towel. This method is inadequate for hazardous spills, as it may not effectively contain or neutralize the chemotherapy drug, leading to potential contamination.
D: Ask the housekeeping department to clean the floor. Relying on housekeeping without proper training in hazardous material cleanup can jeopardize safety; they may not follow the necessary protocols for handling chemotherapy spills.
Correct Answer: C
Rationale: Use a spill kit to clean the area.
Utilizing a spill kit is essential in managing hazardous substances like chemotherapy drugs. It ensures proper containment and minimizes exposure risks, adhering to safety protocols that protect both staff and patients, thereby maintaining a safe environment.
A: Let it dry, and then mop the floor. Allowing the chemical solution to dry poses significant health risks, as it can aerosolize and become hazardous, complicating safe cleanup.
B: Wipe the area with a disposable paper towel. This method is inadequate for hazardous spills, as it may not effectively contain or neutralize the chemotherapy drug, leading to potential contamination.
D: Ask the housekeeping department to clean the floor. Relying on housekeeping without proper training in hazardous material cleanup can jeopardize safety; they may not follow the necessary protocols for handling chemotherapy spills.
Question 7
Regular
Just before the second course of chemotherapy, the laboratory calls to report that the patient's neutrophil count is 450 cells/m?┬│. The nurse expects that the oncologist will follow which course of treatment?
Correct!
Incorrect
The correct answer is: D
Rationale
Chemotherapy will be withheld until the neutrophil count returns toward normal levels. Maintaining adequate neutrophil levels is crucial to prevent serious infections, thereby ensuring patient safety before resuming chemotherapy treatment.
A: Chemotherapy will continue as scheduled. Proceeding with chemotherapy despite low neutrophil counts may expose the patient to significant risk of infection and complications, jeopardizing their health.
B: Chemotherapy will resume with a lowered dosage. Adjusting the dosage does not address the immediate risk posed by the inadequate neutrophil count, which necessitates a delay in treatment.
C: Chemotherapy will resume after a transfusion of neutrophils. Neutrophil transfusions are not a standard treatment option, as they are not typically performed to manage low neutrophil counts in chemotherapy patients.
Correct Answer: D
Rationale: Chemotherapy will be withheld until the neutrophil count returns toward normal levels. Maintaining adequate neutrophil levels is crucial to prevent serious infections, thereby ensuring patient safety before resuming chemotherapy treatment.
A: Chemotherapy will continue as scheduled. Proceeding with chemotherapy despite low neutrophil counts may expose the patient to significant risk of infection and complications, jeopardizing their health.
B: Chemotherapy will resume with a lowered dosage. Adjusting the dosage does not address the immediate risk posed by the inadequate neutrophil count, which necessitates a delay in treatment.
C: Chemotherapy will resume after a transfusion of neutrophils. Neutrophil transfusions are not a standard treatment option, as they are not typically performed to manage low neutrophil counts in chemotherapy patients.
Question 8
Regular
A female patient is receiving palliative therapy with androgen hormones as part of treatment for inoperable breast cancer. The nurse will discuss with the patient which potential body image changes that may occur as adverse effects?
Correct!
Incorrect
The correct answer is: A
Rationale
A: Hirsutism and acne. Androgen hormone therapy can stimulate hair growth in areas typically associated with male patterns, leading to hirsutism, and may also increase oil production in the skin, causing acne.
B: Weight gain. While weight gain can occur due to hormonal changes, it is not as directly related to androgen hormones compared to hirsutism and acne.
C: Flushing and hot flashes. These symptoms are more commonly associated with estrogen depletion or changes, rather than the effects of androgen hormone therapy on body image.
D: Alopecia and body odor. Alopecia may not be a direct effect of androgen hormones, and body odor changes are less significant compared to the more prominent issues of hirsutism and acne.
Correct Answer: A
Rationale: A: Hirsutism and acne. Androgen hormone therapy can stimulate hair growth in areas typically associated with male patterns, leading to hirsutism, and may also increase oil production in the skin, causing acne.
B: Weight gain. While weight gain can occur due to hormonal changes, it is not as directly related to androgen hormones compared to hirsutism and acne.
C: Flushing and hot flashes. These symptoms are more commonly associated with estrogen depletion or changes, rather than the effects of androgen hormone therapy on body image.
D: Alopecia and body odor. Alopecia may not be a direct effect of androgen hormones, and body odor changes are less significant compared to the more prominent issues of hirsutism and acne.
Question 9
Regular
During chemotherapy, a patient develops severe diarrhea caused by a vasoactive intestinal peptide-secreting tumor (VIPoma). The nurse expects to administer which drug for this problem?
Correct!
Incorrect
The correct answer is: C
Rationale
Octreotide. This medication is specifically utilized to mitigate the severe diarrhea associated with VIPomas by inhibiting the secretion of vasoactive intestinal peptide, thereby reducing fluid loss and improving patient comfort during chemotherapy.
A: Dexrazoxane. Primarily designed to protect against cardiotoxicity during chemotherapy, this agent does not address diarrhea or the underlying causes of VIPoma-related symptoms.
B: Allopurinol. This drug is employed in the management of hyperuricemia and does not provide any therapeutic benefit for diarrhea induced by vasoactive intestinal peptide secretion.
D: Bismuth subsalicylate. While effective for general diarrhea, this medication does not target the specific mechanism of VIPoma-related diarrhea and may not provide the necessary symptom relief.
Correct Answer: C
Rationale: Octreotide. This medication is specifically utilized to mitigate the severe diarrhea associated with VIPomas by inhibiting the secretion of vasoactive intestinal peptide, thereby reducing fluid loss and improving patient comfort during chemotherapy.
A: Dexrazoxane. Primarily designed to protect against cardiotoxicity during chemotherapy, this agent does not address diarrhea or the underlying causes of VIPoma-related symptoms.
B: Allopurinol. This drug is employed in the management of hyperuricemia and does not provide any therapeutic benefit for diarrhea induced by vasoactive intestinal peptide secretion.
D: Bismuth subsalicylate. While effective for general diarrhea, this medication does not target the specific mechanism of VIPoma-related diarrhea and may not provide the necessary symptom relief.
Question 10
Multiple Choice
The nurse is assessing a patient who is receiving chemotherapy with an alkylating drug. Which assessment findings would be considered indications of an oncologic emergency? (Select all that apply.)
Correct!
Incorrect
The correct answer is: A,D,E
Rationale
Dry, 'scratchy,' or 'swollen' throat, white patches in the mouth or throat, and a temperature of 100.7°F or higher are all critical signs indicating potential oncologic emergencies in chemotherapy patients.
A: Dry, 'scratchy,' or 'swollen' throat indicates possible infection or mucositis, significant complications for immunocompromised patients.
B: Loss of hair typically results from chemotherapy but does not signify an immediate oncologic emergency.
C: Decreased red blood cell count suggests anemia but lacks the urgency of other symptoms related to infection or severe complications.
D: White patches in the mouth or throat signal possible infection, necessitating immediate intervention in compromised patients.
E: Temperature of 100.7°F or higher indicates fever, a common oncologic emergency signaling infection or neutropenia.
Correct Answer: A,D,E
Rationale: Dry, 'scratchy,' or 'swollen' throat, white patches in the mouth or throat, and a temperature of 100.7°F or higher are all critical signs indicating potential oncologic emergencies in chemotherapy patients.
A: Dry, 'scratchy,' or 'swollen' throat indicates possible infection or mucositis, significant complications for immunocompromised patients.
B: Loss of hair typically results from chemotherapy but does not signify an immediate oncologic emergency.
C: Decreased red blood cell count suggests anemia but lacks the urgency of other symptoms related to infection or severe complications.
D: White patches in the mouth or throat signal possible infection, necessitating immediate intervention in compromised patients.
E: Temperature of 100.7°F or higher indicates fever, a common oncologic emergency signaling infection or neutropenia.
Question 11
Multiple Choice
When a patient is receiving cisplatin chemotherapy, the nurse will monitor for which adverse effects? (Select all that apply.)
Correct!
Incorrect
The correct answer is: A,C,D,E
Rationale
A: Tinnitus, C: Hearing loss, D: Elevated blood urea nitrogen and creatinine levels, E: Numbness or tingling in the extremities. These adverse effects are linked to cisplatin’s nephrotoxicity and ototoxicity, necessitating close monitoring to prevent serious complications during treatment.
B: Heart failure. This condition is not directly associated with cisplatin administration, focusing instead on renal and auditory adverse effects that the drug typically causes.
F: Elevated glucose and ketone levels. Cisplatin does not influence glucose metabolism or lead to ketonuria, as its primary effects are related to renal function and sensory nerve damage.
Correct Answer: A,C,D,E
Rationale: A: Tinnitus, C: Hearing loss, D: Elevated blood urea nitrogen and creatinine levels, E: Numbness or tingling in the extremities. These adverse effects are linked to cisplatin’s nephrotoxicity and ototoxicity, necessitating close monitoring to prevent serious complications during treatment.
B: Heart failure. This condition is not directly associated with cisplatin administration, focusing instead on renal and auditory adverse effects that the drug typically causes.
F: Elevated glucose and ketone levels. Cisplatin does not influence glucose metabolism or lead to ketonuria, as its primary effects are related to renal function and sensory nerve damage.
Question 12
Calculation(ans only)
A patient will be receiving mitoxantrone, 12 mg/m?┬▓/day every 3 weeks, as part of treatment for prostate cancer. Each dose is mixed into a 50-mL bag of D5W and needs to infuse over 15 minutes. The infusion pump delivers the dose at milliliters per hour. Identify the rate the nurse will set the pump to infuse.
Correct!
Incorrect
The correct answer is: 200 ML/HR
Rationale
200 mL/hr
To determine the infusion rate, the total volume of 50 mL must be infused over 15 minutes. Converting 15 minutes to hours gives 0.25 hours, and dividing 50 mL by 0.25 hours results in a rate of 200 mL/hr.
A: 100 mL/hr Infusing at this rate would only deliver 25 mL over 15 minutes, which is insufficient for the prescribed 50 mL.
B: 150 mL/hr This rate would administer 37.5 mL in 15 minutes, falling short of the required 50 mL for the infusion.
C: 250 mL/hr Delivering at this rate would exceed the necessary volume, administering 62.5 mL in 15 minutes, which is more than the prescribed dose.
Correct Answer: 200 ML/HR
Rationale: 200 mL/hr
To determine the infusion rate, the total volume of 50 mL must be infused over 15 minutes. Converting 15 minutes to hours gives 0.25 hours, and dividing 50 mL by 0.25 hours results in a rate of 200 mL/hr.
A: 100 mL/hr Infusing at this rate would only deliver 25 mL over 15 minutes, which is insufficient for the prescribed 50 mL.
B: 150 mL/hr This rate would administer 37.5 mL in 15 minutes, falling short of the required 50 mL for the infusion.
C: 250 mL/hr Delivering at this rate would exceed the necessary volume, administering 62.5 mL in 15 minutes, which is more than the prescribed dose.
Quiz Complete!
Antineoplastic Drugs Part 2: Cell Cycle?Nonspecific Drugs and Miscellaneous Drugs
0%
0
out of
12
questions correct